Strategic Financial Concepts LLC Makes New $8.73 Million Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Strategic Financial Concepts LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 94,191 shares of the exchange traded fund’s stock, valued at approximately $8,732,000. Strategic Financial Concepts LLC owned 0.12% of SPDR S&P Biotech ETF as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. HBK Sorce Advisory LLC lifted its stake in SPDR S&P Biotech ETF by 2.6% in the first quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock worth $431,000 after acquiring an additional 113 shares during the last quarter. Intellectus Partners LLC raised its holdings in shares of SPDR S&P Biotech ETF by 1.0% in the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after purchasing an additional 113 shares in the last quarter. Concourse Financial Group Securities Inc. lifted its position in shares of SPDR S&P Biotech ETF by 21.2% during the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock worth $59,000 after purchasing an additional 115 shares during the last quarter. Pacific Center for Financial Services grew its stake in shares of SPDR S&P Biotech ETF by 2.8% during the first quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock worth $414,000 after purchasing an additional 118 shares in the last quarter. Finally, Kingsview Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF by 3.8% in the first quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after buying an additional 127 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $96.52 on Friday. The stock’s fifty day moving average is $97.74 and its two-hundred day moving average is $93.81. The stock has a market cap of $7.36 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $63.80 and a 1-year high of $103.52.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.